Publications by authors named "Elisabeth Brambilla"

100Publications

The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non-Small Cell Lung Cancer.

J Thorac Oncol 2020 03 13;15(3):344-359. Epub 2019 Nov 13.

Department of Thoracic Surgery, Hospital Universitari Mutua Terrassa, University of Barcelona, Terrassa, Barcelona, Spain; Network of Centres for Biomedical Research in Respiratory Diseases (CIBERES) Lung Cancer Group, Terrassa, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.10.019DOI Listing
March 2020

A Rare Fusion of CLIP1 and ALK in a Case of Non-Small-Cell Lung Cancer With Neuroendocrine Features.

Clin Lung Cancer 2019 09 11;20(5):e535-e540. Epub 2019 May 11.

Université Grenoble Alpes, Grenoble, France; Plateforme de Génétique Moléculaire des Cancers, Pôle de Biologie et Pathologie, CHU Grenoble Alpes, Grenoble, France; Département d'Anatomie et Cytologie Pathologiques, Pôle de Biologie et Pathologie, CHU Grenoble Alpes, Grenoble, France; UGA/INSERM U1209/CNRS 5309-Institute for Advanced Biosciences - Université Grenoble Alpes, Grenoble, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2019.05.001DOI Listing
September 2019

Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer.

J Clin Oncol 2018 10 14;36(30):2995-3006. Epub 2018 Aug 14.

Siddhartha Devarakonda, Irena Lanc, and Ramaswamy Govindan, Washington University School of Medicine; Siddhartha Devarakonda and Ramaswamy Govindan, Siteman Cancer Center; Robert Fulton, Washington University School of Medicine, St. Louis; Ashiq Masood, University of Missouri Kansas City, Kansas City, MO; Federico Rotolo, Ken A. Olaussen, Gwénaël Le Teuff, Jean-Pierre Pignon, and Stefan Michiels, Université Paris-Saclay; Federico Rotolo, Ken A. Olaussen, Gwénaël Le Teuff, Jean-Pierre Pignon, Jean-Charles Soria, and Stefan Michiels, Gustave Roussy Cancer Campus, Villejuif; Elisabeth Brambilla and Anne McLeer-Florin, Centre Hospitalier Universitaire de Grenoble, La Tronche, France; Ming-Sound Tsao, Shingo Sakashita, and Frances A. Shepherd, Princess Margaret Cancer Centre and University of Toronto, Toronto; Keyue Ding and Lesley Seymour, Queen's University Kingston, Ontario, Canada; Stephen L. Graziano, State University of New York Upstate Medical University, Syracuse, NY; Robert Kratzke, University of Minnesota Medical School, Minneapolis, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.1963DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804865PMC
October 2018

-Oncogenic and -Inactivating Alterations Are Independent Factors That Affect Regulation of PD-L1 Expression in Lung Cancer.

Clin Cancer Res 2018 09 13;24(18):4579-4587. Epub 2018 Jun 13.

Genes and Cancer Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-18-0267DOI Listing
September 2018

ALK fusion variants detection by targeted RNA-next generation sequencing and clinical responses to crizotinib in ALK-positive non-small cell lung cancer.

Lung Cancer 2018 02 8;116:15-24. Epub 2017 Dec 8.

UGA/INSERM U1209/CNRS 5309-Institute for Advanced Biosciences-Université Grenoble Alpes, Grenoble, France; Université Grenoble Alpes, Grenoble, France; Département de biopathologie-MESOPATH, Centre de Lutte Contre le Cancer Léon Bérard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.12.004DOI Listing
February 2018

Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer.

Genes Dev 2016 Apr 17;30(7):772-85. Epub 2016 Mar 17.

Department of Pediatrics, Stanford University School of Medicine, Stanford, California 94305, USA; Department of Genetics, Stanford University School of Medicine, Stanford, California 94305, USA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/gad.275529.115DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826394PMC
April 2016

Immune biomarkers PD-1/PD-L1 and TLR3 in malignant pleural mesotheliomas.

Hum Pathol 2016 06 5;52:9-18. Epub 2016 Feb 5.

Département de Biopathologie, Centre Léon Bérard, 69008 Lyon, Université Joseph Fourier INSERM U 823, Institut A. Bonniot, 38700 La Tronche, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2016.01.010DOI Listing
June 2016

Histological grading in lung cancer: one system for all or separate systems for each histological type?

Eur Respir J 2016 Mar;47(3):720-3

Dept of Pathology, University of Mississippi Medical Center, Jackson, MS, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.00035-2016DOI Listing
March 2016

Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis.

J Thorac Oncol 2016 06 17;11(6):850-61. Epub 2016 Feb 17.

International Agency for Research on Cancer, Lyon, France; Department of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada; Department of Pathology, Centre Hospitalier Universitaire, Grenoble, France; International Prevention Research Institute, Lyon, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.02.002DOI Listing
June 2016

Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer.

J Clin Oncol 2016 Apr 1;34(11):1223-30. Epub 2016 Feb 1.

Elisabeth Brambilla and Sylvie Lantuejoul, Institut Albert Bonniot-Institut National de la Santé et de la Recherche Médicale U823; and Centre Hospitalier Universitaire Albert Michallon, Grenoble; Gwénaël Le Teuff, Sophie Marguet, Ariane Dunant, Thierry Le Chevalier, and Jean-Charles Soria, Institut Gustave Roussy, Villejuif; Gwénaël Le Teuff, Sophie Marguet, Ariane Dunant, Thierry Le Chevalier, and Jean-Charles Soria, Université Paris-Sud, Orsay; Gwénaël Le Teuff, Université Paris-Saclay, Saint-Aubin; Jean-Yves Douillard, Centre René Gauducheau Institut de Cancerologie de l'Ouest, Saint-Herblain, France; Stephen Graziano, State University of New York Upstate Medical University, Syracuse, NY; Robert Pirker and Martin Filipits, Medical University of Vienna, Vienna; Helmut Popper, Medical University of Graz, Graz, Austria; Rafael Rosell, Catalan Institute of Oncology, Barcelona, Spain; Robert Kratzke, University of Minnesota, Minneapolis, MN; Frances A. Shepherd and Ming Sound Tsao, Princess Margaret Cancer Centre; Frances A. Shepherd and Ming Sound Tsao, University of Toronto, Toronto; and Lesley Seymour, Queen's University, Kingston, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.0970DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872323PMC
April 2016

[New WHO classification of lung adenocarcinoma and preneoplasia].

Ann Pathol 2016 Jan 11;36(1):5-14. Epub 2016 Jan 11.

Department of pathology, memorial Sloan Kettering cancer center, New York, NY, États-Unis.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2015.11.010DOI Listing
January 2016

Cell adhesion and polarity in squamous cell carcinoma of the lung.

J Pathol 2016 Apr 29;238(5):606-16. Epub 2016 Feb 29.

Genes and Cancer Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.4686DOI Listing
April 2016

Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.

J Thorac Oncol 2015 Sep;10(9):1240-1242

Department of Histopathology, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000663DOI Listing
September 2015

Comprehensive genomic profiles of small cell lung cancer.

Nature 2015 Aug 13;524(7563):47-53. Epub 2015 Jul 13.

1] Department of Translational Genomics, Center of Integrated Oncology Cologne-Bonn, Medical Faculty, University of Cologne, 50931 Cologne, Germany. [2] Department of Pathology, University Hospital Cologne, 50937 Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature14664DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861069PMC
August 2015

Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.

J Clin Oncol 2015 Oct 27;33(30):3439-46. Epub 2015 Apr 27.

Ming-Sound Tsao and Frances A. Shepherd, Princess Margaret Cancer Centre, University Health Network, and University of Toronto, Toronto; Lesley Seymour, NCIC Clinical Trials Group and Queen's University, Kingston, Ontario, Canada; Sophie Marguet, Gwénaël Le Teuff, Thierry Le-Chevalier, Jean-Pierre Pignon, and Jean-Charles Soria, Gustave Roussy, Villejuif; Sylvie Lantuejoul and Elisabeth M. Brambilla, Inserm U823, Centre Hospitalier Universitaire de Grenoble, Institut Albert Bonniot, Université Joseph Fourier, Grenoble; Jean-Yves Douillard, Centre René Gauducheau, Saint-Herblain, Nantes, France; Robert Kratzke, University of Minnesota, Minneapolis, MN; Stephen L. Graziano, SUNY Upstate Medical University, Syracuse, NY; Helmut H. Popper, Institute of Pathology, University Medical School of Graz, Graz, Austria; and Rafael Rosell, Catalan Institute of Oncology, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.8335DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606061PMC
October 2015

Chlorotoxin: a helpful natural scorpion peptide to diagnose glioma and fight tumor invasion.

Toxins (Basel) 2015 Mar 27;7(4):1079-101. Epub 2015 Mar 27.

Grenoble Neuroscience Institute, Inserm U836, Team 3, Chemin Fortuné Ferrini, Bâtiment Edmond Safra, 38042 Grenoble Cedex 09, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/toxins7041079DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417956PMC
March 2015

The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung.

J Thorac Oncol 2015 Apr;10(4):553-64

*Hamon Center for Therapeutic Oncology Research and Department of Pathology, UT Southwestern Medical Center, Dallas, TX; †Department of Neuroscience, UT Southwestern Medical Center, Dallas, TX; ‡Cancer Genomics Centre, The Netherlands Cancer Institute, Amsterdam, The Netherlands; §Departments of Pediatrics and Genetics, Stanford University, Stanford, CA; ‖Center for Cancer Research, National Cancer Institute, Bethesda, MD; ¶Division of Human Biology and Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA; #David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142; **Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY; and ††Departementd'Anatomie et Cytologie Pathologiques, INSERM Unit 823, Centre Hospitalier Universitaire Albert Michallon, and Institut Albert Bonniot University, Grenoble, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000459DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523224PMC
April 2015

Forty years of the international association for study of lung cancer pathology committee.

J Thorac Oncol 2014 Dec;9(12):1740-9

*Department of Pathology, University Health Network-Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; †Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York; ‡Département d'Anatomie et de Pathologique Cytologiques, CHU Albert Michallon INSERM U823/Université Joseph Fourier, Grenoble, France; §Department of Histopathology, Royal Brompton Hospital, London, United Kingdom; ‖Department of Pathology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan; and ¶University of Colorado Cancer Center, Department of Pathology and Division of Medical Oncology, University of Colorado Denver, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000356DOI Listing
December 2014

Lung squamous cell carcinomas with basaloid histology represent a specific molecular entity.

Clin Cancer Res 2014 Nov 4;20(22):5777-86. Epub 2014 Sep 4.

Département d'Anatomie et Cytologie Pathologique, Centre Hospitalier Universitaire de Grenoble, Institut Albert Bonniot, INSERM U823, Université Joseph Fourrier, Grenoble, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-0459DOI Listing
November 2014

Reproducibility of histopathological diagnosis in poorly differentiated NSCLC: an international multiobserver study.

J Thorac Oncol 2014 Sep;9(9):1354-62

Departments of *Pathology and ††††Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands; †Department of Pathology, Faculty of Medicine, Tsukuba, Japan; ‡Rutgers New Jersey Medical School, Newark, New Jersey; §Department of Pathology, Mount Sinai Medical Center, New York, New York; ‖Elisabeth Brambilla, CHU Albert Michallon, Institut de Biologie, Département d'Anatomie et Cytologie Pathologiques, Grenoble Cedex, France; ¶Brigham and Women's Hospital, Boston, Massachusetts; #Department of Pathology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea; **Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania; ††Piedmont Pathology Associates, Hickory, North Carolina, and University of North Carolina, Chapel Hill, North Carolina; ‡‡Department of Medicine and Pathology, University of Colorado Cancer Center, Aurora, Colorado; §§Division of Pathology, The Cancer Institute, Japanese Foundation Cancer Research, Tokyo, Japan; ‖Department of Pathology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom; ¶¶Department of Pathology, CHU A Michallon, INSERM U 823-Institut A Bonniot-University J Fourier, Grenoble, France; ##Department of Pathology, Cancer Center Hospital, Tsukuba, Japan; ***Department of Pathology, Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Japan; †††Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York; ‡‡‡Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale Tumori, and Università degli Studi of Milan, Milan, Italy; §§§Institut für Pathologie, Jena, Germany; ‖‖‖Duke University Medical Center, Durham, North Carolina; ¶¶¶University of Texas MD Anderson Cancer Center, Houston, Texas; ###Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan; ****Department of Oncology and Radiothe

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000264DOI Listing
September 2014

Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer.

Mol Oncol 2014 May 15;8(3):555-64. Epub 2014 Jan 15.

University of Strathclyde School of Global Public Health at iPRI, International Prevention Research Institute, Lyon, France; Institut Albert Bonniot, Institut National de la Santé et de la Recherche Médicale U 823, Grenoble, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2013.12.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528648PMC
May 2014

CD74-NRG1 fusions in lung adenocarcinoma.

Cancer Discov 2014 Apr 27;4(4):415-22. Epub 2014 Jan 27.

1Department of Translational Genomics; 2Department I of Internal Medicine; 3Laboratory of Translational Cancer Genomics; 4Network Genomic Medicine, University Hospital Cologne, Center of Integrated Oncology Cologne-Bonn; 5Center for Molecular Medicine Cologne (CMMC); 6Cologne Center for Genomics (CCG); 7Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD); 8Department of Pathology, University Hospital Medical Center, University of Cologne; 9Blackfield AG; 10Max Planck Institute for Neurological Research; 11Thoracic Surgery, Lungenklinik Merheim, Kliniken der Stadt Köln gGmbH; 12Institute of Human Genetics, Cologne; 13Computational Molecular Biology Department, Max Planck Institute for Molecular Genetics, Berlin; 14Department of Prostate Cancer Research, Institute of Pathology; 15Institute for Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn; 16Institute of Pathology; 17Department of Internal Medicine II, Jena University Hospital, Friedrich-Schiller-University, Jena; 18Institute for Pathology Bad Berka, Bad Berka, Germany;19Division of Molecular Oncology, Aichi Cancer Center Research Institute; 20Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan; Departments of 21Surgery and22Pathology, St. Vincent's Hospital; 23Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;24Department of Pathology, 25CHU Grenoble Institut National de la Santé et de la Recherche Medicale (INSERM) U823, Institute Albert Bonniot, Grenoble-Alpes University, Grenoble, France; 26Laboratory of Oncology IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo; 27Laboratory for Molecular Medicine and Biotechnology, University Campus Bio-Medico, Rome, Italy; 28Center for the Biology of Disease, VIB, Leuven; and 29Oncology Discovery, Janssen Research and Development, A Division of Janssen Pharmaceutica NV, Beerse, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-13-0633DOI Listing
April 2014

Immunohistochemistry evaluation of biomarker expression in non-small cell lung cancer (Pharmacogenoscan study).

Lung Cancer 2014 Feb 21;83(2):182-8. Epub 2013 Dec 21.

Université Grenoble 1, INSERM, U 823, Institut A Bonniot, Université J Fourier, Rond-point de la Chantourne, 38706 La Tronche Cedex, France; Department of Pathology, Teaching Hospital A Michallon, BP217, 38043 Grenoble Cedex 9, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.12.003DOI Listing
February 2014

On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas.

Lung Cancer 2014 Feb 1;83(2):168-73. Epub 2013 Dec 1.

Département d'Anatomie et Cytologie Pathologiques, Pôle de Biologie et Pathologie, CHU Grenoble, France; Plateforme de Génétique Moléculaire des Tumeurs, Pôle de Biologie et Pathologie, CHU Grenoble, France; INSERM U 823-Institut A Bonniot-Université J Fourier, Grenoble, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.11.019DOI Listing
February 2014

The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism.

Int J Cancer 2014 Jun 13;134(11):2560-71. Epub 2013 Dec 13.

INSERM U823, Grenoble, France; University UJF Grenoble 1, Grenoble, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28594DOI Listing
June 2014

Lung adenocarcinoma expression profile: one more layer of heterogeneity.

Eur Respir J 2013 Nov;42(5):1180-2

Institute Albert Bonniot, University Joseph Fourier, and Dept of Pathology, Grenoble University Hospital, Grenoble, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/09031936.00087213DOI Listing
November 2013

Mutation of TP53 and alteration of p14(arf) expression in EGFR- and KRAS-mutated lung adenocarcinomas.

Clin Lung Cancer 2014 Mar 26;15(2):124-30. Epub 2013 Oct 26.

Department of Translational Research, Institut Gustave Roussy, Villejuif, France; INSERM Unit 981, University Paris-South, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2013.08.003DOI Listing
March 2014

Strategies for improving outcomes in NSCLC: a look to the future.

Lung Cancer 2013 Dec 8;82(3):375-82. Epub 2013 Sep 8.

Department of Oncology, University Hospital Zurich, Zurich, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.08.025DOI Listing
December 2013

A prognostic DNA methylation signature for stage I non-small-cell lung cancer.

J Clin Oncol 2013 Nov 30;31(32):4140-7. Epub 2013 Sep 30.

Juan Sandoval, Jesus Mendez-Gonzalez, F. Javier Carmona, Sergi Sayols, Sebastian Moran, Holger Heyn, Miguel Vizoso, Antonio Gomez, Montse Sanchez-Cespedes, and Manel Esteller, Bellvitge Biomedical Research Institute; Josefina Mora, Hospital de la Santa Creu i Sant Pau; Manel Esteller, University of Barcelona and Institucio Catalana de Recerca i Estudis Avançats, Barcelona; Miquel Taron and Rafael Rosell, Catalan Institute of Oncology, Badalona, Catalonia; Marina Pollan, Instituto de Salud Carlos III, Madrid; Maria J. Pajares and Luis M. Montuenga, University of Navarra; Wenceslao Torre, Clínica University de Navarra, Pamplona, Spain; Ernest Nadal, Guoan Chen, and David G. Beer, University of Michigan Medical School, Ann Arbor, MI; Yassen Assenov and Fabian Müller, Max Planck Institute, Saarbrücken, Germany; Christoph Bock, Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria; Lucia A. Muscarella, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy; Triantafillos Liloglou, Michael Davies, and John K. Field, The University of Liverpool Cancer Research Centre, Liverpool, United Kingdom; Elisabeth Brambilla, Centre Hospitalier Universitaire A Michallon, Grenoble, France; Luca Roz, IRCCS Foundation National Cancer Institute, Milan; Marco Lo Iacono and Giorgio V. Scagliotti, University of Torino, Orbassano (Torino), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.48.5516DOI Listing
November 2013

Adequacy of CT-guided biopsies with histomolecular subtyping of pulmonary adenocarcinomas: influence of ATS/ERS/IASLC guidelines.

Lung Cancer 2013 Oct 5;82(1):69-75. Epub 2013 Aug 5.

Clinique Universitaire de Radiologie et Imagerie Médicale, Centre Hospitalier Universitaire A Michallon, INSERM U 823-Institut A Bonniot-Université J Fourier, Grenoble, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.07.010DOI Listing
October 2013

A new function of the splicing factor SRSF2 in the control of E2F1-mediated cell cycle progression in neuroendocrine lung tumors.

Cell Cycle 2013 Apr 21;12(8):1267-78. Epub 2013 Mar 21.

INSERM, U823, Equipe 2 Bases Moléculaires de la Progression des Cancers du Poumon, Grenoble, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.24363DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674091PMC
April 2013

New pathologic classification of lung cancer: relevance for clinical practice and clinical trials.

J Clin Oncol 2013 Mar 11;31(8):992-1001. Epub 2013 Feb 11.

Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.46.9270DOI Listing
March 2013

Determining the profiles and parameters for gene amplification testing of growth factor receptors in lung cancer.

Int J Cancer 2013 Aug 9;133(4):898-907. Epub 2013 Mar 9.

Genes and Cancer Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28090DOI Listing
August 2013

Radiologic implications of the 2011 classification of adenocarcinoma of the lung.

Radiology 2013 Jan 15;266(1):62-71. Epub 2012 Oct 15.

Department of Radiology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032, USA.

View Article

Download full-text PDF

Source
http://pubs.rsna.org/doi/10.1148/radiol.12120240
Publisher Site
http://dx.doi.org/10.1148/radiol.12120240DOI Listing
January 2013

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.

Nat Genet 2012 Oct 2;44(10):1104-10. Epub 2012 Sep 2.

Department of Translational Genomics, University of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.2396DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915822PMC
October 2012

Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities.

Clin Cancer Res 2012 May 8;18(9):2443-51. Epub 2012 Mar 8.

Département de Médecine, Unité INSERM U 981, Université Paris Sud, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2370DOI Listing
May 2012

Activation of a Tip60/E2F1/ERCC1 network in human lung adenocarcinoma cells exposed to cisplatin.

Carcinogenesis 2012 Feb 9;33(2):320-5. Epub 2011 Dec 9.

Equipe Bases Moléculaires de la Progression des Cancers du Poumon, Centre de Recherche INSERM U823, Institut Albert Bonniot BP170, 38042 Grenoble Cedex 09, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgr292DOI Listing
February 2012

Preneoplasia of lung cancer.

Cancer Biomark 2010 ;9(1-6):385-96

Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical School, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/CBM-2011-0166DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428013PMC
July 2012

Dual IHC and FISH testing for ALK gene rearrangement in lung adenocarcinomas in a routine practice: a French study.

J Thorac Oncol 2012 Feb;7(2):348-54

Plateforme hospitalière de Génétique Moléculaire des Cancers, Department of Hematology, Onco-Genetics and Immunology, Päle de Biologie et de Pathologie, CHU A Michallon, Grenoble, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3182381535DOI Listing
February 2012

The multiple roles of amphiregulin in human cancer.

Biochim Biophys Acta 2011 Dec 30;1816(2):119-31. Epub 2011 May 30.

INSERM, U823, Institut Albert Bonniot, Grenoble, France, Université Joseph Fourier, Grenoble, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbcan.2011.05.003DOI Listing
December 2011

SRSF2 is required for sodium butyrate-mediated p21(WAF1) induction and premature senescence in human lung carcinoma cell lines.

Cell Cycle 2011 Jun 15;10(12):1968-77. Epub 2011 Jun 15.

Equipe 2 Bases Moléculaires de la Progression des Cancers du Poumon, Grenoble, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.10.12.15825DOI Listing
June 2011

Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin.

EMBO J 2011 Feb 14;30(3):510-23. Epub 2010 Dec 14.

INSERM, U823, Equipe 2 Bases Moléculaires de la Progression des Cancers du Poumon, Institut Albert Bonniot, Grenoble, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/emboj.2010.333DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034009PMC
February 2011

[New classification of pulmonary cancer: application to small size biopsy sampling].

Ann Pathol 2010 Nov 15;30(5 Suppl 1):60-3. Epub 2010 Sep 15.

Département d'anatomie et cytologie pathologiques, CHU Albert Michallon, BP 217, Grenoble cedex 09, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2010.07.033DOI Listing
November 2010

The ARF tumor suppressor: structure, functions and status in cancer.

Int J Cancer 2010 Nov;127(10):2239-47

Equipe Bases Moléculaires de la Progression des Cancers du Poumon, Centre de Recherche INSERM U823, Institut Albert Bonniot, 38042 Grenoble Cedex 09, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.25511DOI Listing
November 2010